Solventum Corporation logo SOLV - Solventum Corporation

NEXT EARNINGS: Feb 26, 2026 (in 1 day) EPS Est: $1.50 | Rev Est: $2.0B
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 3
SELL 1
STRONG
SELL
0
| PRICE TARGET: $95.80 DETAILS
HIGH: $105.00
LOW: $77.00
MEDIAN: $100.00
CONSENSUS: $95.80
UPSIDE: 30.48%
Market Cap: 12.73B
Volume: 579,787
Avg Volume: 1,123,254
52 Week Range: 60.7-88.2
Sector: Healthcare
Industry: Medical - Care Facilities
Beta: 0.51
Last Dividend: $N/A
Exchange: NYSE
Country: US
Employees: 22,000
IPO Date: 2024-04-01
EPS (TTM): 2.77
P/E Ratio: 23.89
Revenue (TTM): 8.25B
Total Assets: 14.46B
Total Debt: 8.01B
Cash & Equiv: 762.00M
Rev Growth (5Y): 3.2%
EPS Growth (5Y): -19.5%
FCF Growth (5Y): -17.7%
ROCE: 8.3%
Debt/Equity: 2.71

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-06 $1.50 $1.43 +4.9% $2.1B $2.1B +2.0%
2025-08-07 $1.69 $1.45 +16.6% $2.2B $2.1B +2.0%
2025-05-08 $1.34 $1.21 +10.7% $2.1B $2.0B +2.7%
2025-02-27 $1.41 $1.31 +7.6% $2.1B $2.1B +1.1%
2024-11-07 $1.64 $1.39 +18.0% $2.1B $2.1B +1.2%
2024-08-08 $1.56 $1.51 +3.3% $2.1B $2.0B +1.6%
2024-05-09 $2.08 $1.75 +18.9% $2.0B $2.0B +2.5%
2023-12-31 $0.42 $2.1B

Track Record

Statements >
Metric 2024 2023 2022 2021 2020
Revenue 8.25B 8.20B 8.13B 8.17B 7.28B
Net Income 479.00M 1.35B 1.34B 1.46B 1.14B
EPS 2.77 7.79 7.79 8.47 6.60
Total Assets 14.46B 13.94B 13.59B 14.07B N/A
Total Debt 8.01B 8.30B 0 0 N/A
Cash & Equivalents 762.00M 194.00M 61.00M 91.00M N/A
Operating Cash Flow 1.19B 1.92B 1.68B 2.20B 2.03B
Free Cash Flow 805.00M 1.62B 1.43B 1.93B 1.75B
FCF per Share 4.65 9.41 8.28 11.16 10.18
Book Value 2.96B 11.67B 11.74B 12.06B N/A
Cash & ST Investments 762.00M 194.00M 61.00M 91.00M N/A
ROC Equity 0.16 0.12 0.11 0.12 N/A